Skip to main content
Signal8

LYTLE PAUL J

SEC insider (Form 3/4/5 filer). CIK 0001244110. Chief Financial Officer at ACTUATE THERAPEUTICS, INC. (ACTU). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in FORT WORTH, TX.

Companies LYTLE PAUL J has filed insider reports for

  • ACTUATE THERAPEUTICS, INC. (ACTU): Officer, Chief Financial Officer
LYTLE PAUL J profile photo

LYTLE PAUL J

CIK: 0001244110

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACTUATE THERAPEUTICS, INC. logo
ACTU

ACTUATE THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ACTUATE THERAPEUTICS, INC. logo
    ACTU

    ACTUATE THERAPEUTICS, INC.

    Apr 1, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    105K shares-
  • ACTUATE THERAPEUTICS, INC. logo
    ACTU

    ACTUATE THERAPEUTICS, INC.

    Apr 1, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    49.4K shares-
  • ACTUATE THERAPEUTICS, INC. logo
    ACTU

    ACTUATE THERAPEUTICS, INC.

    Apr 1, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    41.9K shares-

1-3 of 3